Ajanta Pharma share news, announcements and annual reports
NSE: AJANTPHARMBSE: 532331Pharmaceuticals & BiotechnologyMid Cap
Ajanta Pharma Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2000 on NSE, Jun 2000 on BSE
Last close ₹3,508.80up ₹49.10 (1.42%)BSE ₹3,512.40
Share price at the NSE close on 30 Oct 2026. Previous close ₹3,459.70.
30 Oct: open ₹3,479.00, high ₹3,619.90, low ₹3,460.50
52-week range of traded prices to 30 Oct 2026
₹2,430.00Low, 30 Oct 2025₹3,796.00High, 18 Aug 2026
- Next results date: the board meets on 30 Oct 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹43,846 Cr236th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 34.72
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 9.02
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.71%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 27.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 30.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.02
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 9,52,55826.6% delivered
Ajanta Pharma shareholder meetings
69 filed, newest first. Page 1 of 2.
Jul 2026
16 Jul · Meeting
Jun 2026
18 Jun · Meeting
Jul 2025
17 Jul · Meeting
Jul 2024
18 Jul · Meeting
Jun 2024
Jul 2023
18 Jul · Meeting
Jun 2023
16 Jun · Meeting
Mar 2023
Feb 2023
7 Feb · Meeting
Aug 2022
4 Aug · Meeting
Jun 2022
13 Jun · Meeting
May 2022
Jul 2021
14 Jul · Meeting
Jun 2021
3 Jun · Meeting
Jul 2020
31 Jul · Meeting
Jul 2019
18 Jul · Meeting
Jul 2018
6 Jul · Meeting
May 2018
Oct 2017
Sep 2017
Jul 2017
6 Jul · Meeting
May 2017
Jul 2016
May 2016
Jul 2015
Jun 2015
Mar 2015
Feb 2015
Jan 2015
Aug 2014
Jun 2014
10 Jun · Meeting
Company shall close its Equity Share Transfer Books for a period from July 28, 2014 to August 05, 2014 (both days inclusive) for the purpose of dividend. Further, the Annual General Meeting of the Company is scheduled to be held on August 05, 2014.
Oct 2013
Sep 2013
Aug 2013
Jul 2013
May 2013
22 May · Meeting
Company shall close its Equity Share Transfer Books for a period from July 22, 2013 to July 26, 2013 (both days inclusive) for the purpose of dividend. The dividend will be paid to the shareholders if the same is approved by the shareholders in the Annual General Meeting to be held on July 26, 2013.22 May · Meeting
Ajanta Pharma Limited had informed the Exchange that the Board of Directors of the Company at its meeting held on April 30, 2013 had recommended dividend @ Rs. 6.25 per equity share of the face value of Rs. 5/- each, subject to approval of shareholders at the ensuing Annual General Meeting to be held on July 13, 2013. The Company has now informed that the Company has inadvertently informed that the Annual General Meeting of the Company would be held on July 13, 2013. Further, the Company has informed that the Annual General Meeting of the Company will be held on July 26, 2013.